Amanote Research

Amanote Research

    RegisterSign In

223 Cancer-Type SLCO1B3 as a Biomarker for Epidermolysis Bullosa-Associated Skin Cancer

Journal of Investigative Dermatology - United Kingdom
doi 10.1016/j.jid.2018.03.228
Full Text
Open PDF
Abstract

Available in full text

Categories
BiochemistryDermatologyCell BiologyMolecular Biology
Date

May 1, 2018

Authors
C. Guttmann-GruberK. WössY. SunT. FurihataJ. ReicheltJ. Piñón Hofbauer
Publisher

Elsevier BV


Related search

Multicentre Consensus Recommendations for Skin Care in Inherited Epidermolysis Bullosa

Orphanet Journal of Rare Diseases
MedicineGeneticsPharmacology
2014English

Gastrostomy for Epidermolysis Bullosa

British Journal of Dermatology
DermatologyMedicine
2018English

Junctional Epidermolysis Bullosa

2020English

Gene Therapy for Epidermolysis Bullosa

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Epidermolysis Bullosa Acquisita

2004English

Epidermolysis Bullosa Hereditaria

Medizinische Genetik
Genetics
2019English

Epidermolysis Bullosa Simplex

2020English

Epidermolysis Bullosa Acquisita

Clinics in Dermatology
Dermatology
2012English

Intravenously Injected Recombinant Human Type VII Collagen Homes to Skin Wounds and Restores Skin Integrity of Dystrophic Epidermolysis Bullosa

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy